3 liver cancer treatments you should know about

Escrito por: Dr Julian Hague
Publicado: | Actualizado: 11/04/2023
Editado por: Cal Murphy

Around 5,700 people in the UK are diagnosed with liver cancer each year – this works out to around 16 new cases every day! Luckily, there are several treatment options to combat this disease. Leading clinical and interventional radiologist Dr Julian Hague talked to us about three liver cancer treatments you might not know about, but should.

What is TACE (transarterial chemo-embolisation)?

The TACE procedure is a method of sending high dose chemotherapy into the liver via the arteries.

Some varieties of liver tumour can be very difficult to treat with the usual chemotherapy methods (such as injections and tablets). In some cases, these tumours can be treated by inserting a thin catheter or tube into the main artery in the top of the thigh and then guiding it through the artery to the liver, using X-rays to see where it is. TACE is often done under local anaesthetic or light sedation.

 

What is chemosaturation?

Liver chemosaturation is a new technique aimed at delivering very high doses of chemotherapy into the liver whilst on a liver bypass machine (similar to a heart bypass machine). This is done under a general anaesthetic. Whilst it is relatively new, this has been shown to be very effective for certain types of tumour (such as ocular melanoma metastases to the liver). There are also several ongoing trials looking at this procedure in other tumour types.

 

What is SIRT (selective internal radiation therapy)?

SIRT is a way of delivering high dose of radioactive particles into liver tumours, in a similar way to TACE. This is a relatively new technique but has been shown to be effective for tumours such as colorectal liver metastases, hepatocellular carcinoma, and breast cancer. These treatments are usually discussed with your oncologist if they feel it is appropriate in your case. Most of the time, this can be done under local anaesthetic or light sedation. Recovery back to normal activities normally takes around a week.

 

Dr Hague is an expert in interventional radiology and chemoembolisation techniques, and works in a team of specialists (including anaesthetists, oncologists, specialist nurses) to deliver these treatments.

Por Dr Julian Hague
Neurorradiología Intervencionista

El Dr. Julian Hague es un radiólogo clínico e intervencionista líder con sede en Londres. Se especializa en procedimientos endovasculares, tratamientos de tumores dirigidos al hígado y en el tratamiento de la trombosis venosa profunda. Es un experto en la quimioembolización hepática (DEB-TACE), un procedimiento para tratar ciertos tipos de cáncer que administra una gran dosis de quimioterapia directamente a los tumores hepáticos.

Calificado por el Royal Free Hospital en 1995, el Dr. Hague se capacitó posteriormente en University College Hospitals y Middlesex Hospital, adquiriendo las habilidades en cirugía y radiología que hoy lo convierten en uno de los mejores en su campo. Se convirtió en miembro del Royal College of Radiologists (FRCR) en 2006, luego de lo cual fue nombrado consultor radiólogo tanto en la UCH como en la Royal Free. El Dr. Hague participa activamente en la investigación y su trabajo ha sido ampliamente publicado.

Ver perfil

Valoración general de sus pacientes


  • Tratamientos relacionados
  • Benign prostate enlargement
    Varicocele
    Breast cancer
    Cardiac MRI
    Alzheimer's disease
    Ultrasound
    Endovenous laser treatment (EVLA)
    Vertebroplasty
    Nervous system malformations
    Brain aneurysm
    Este sitio web utiliza Cookies propias y de terceros para recopilar información con la finalidad de mejorar nuestros servicios, para mostrarle publicidad relacionada con sus preferencias, así como analizar sus hábitos de navegación. El usuario tiene la posibilidad de configurar sus preferencias AQUI.